Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
2021 · JAMA Surgery · 315 citations
https://doi.org/10.1001/jamasurg.2021.2373
J
Jiaqing Xiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
180
Papers
5.8K
Citations
38
h-index
97
i10-index
Jiaqing Xiang is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 38, co-authored 153 publications.
ORCID: 0000-0001-9636-2150Papers by this author
worksComparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations
2017 · Nature Communications · 127 citations
https://doi.org/10.1038/s41467-017-01730-x
HIMF deletion ameliorates acute myocardial ischemic injury by promoting macrophage transformation to reparative subtype
2021 · Basic Research in Cardiology · 45 citations
https://doi.org/10.1007/s00395-021-00867-7
Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
2015 · Journal of Experimental & Clinical Cancer Research · 30 citations
https://doi.org/10.1186/s13046-015-0212-z
Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction
2020 · Aging and Disease · 28 citations
https://doi.org/10.14336/ad.2019.0522
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway
2021 · Diabetologia · 26 citations
https://doi.org/10.1007/s00125-021-05616-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat